Volume 48, Issue 7 , Pages 721-729, July 2009
Escitalopram in the Treatment of Adolescent Depression: A Randomized Placebo-Controlled Multisite Trial
To access this article, please choose from the options below
This study was supported by Forest Laboratories.The authors thank the SCT-MD-32 investigators for the contribution (Valerie Kaplan Arnold, Eric Bartky, Louise M. Beckett-Thurman, Grant B. Belnap, Deborah Bergen, Shashi Bhatia, Regina Bussing, Rajinder S. Dhillon, Graham Emslie, Anne C. Fedyszen, Robert L. Findling, Michael Greenbaum, C. Thomas Gualtieri, Sanjay Gupta, Paras Harshawat, Howard A. Hassman, Robert L. Hendren, Henry B. Kaplan, Arifulla Khan, Irving Kolin, James E. Lee, Robert B. Lehman, Alan J. Levine, Gregory M. Mattingly, Michael E. McManus, Janice L. Miller, William Rory Murphy, Kamalesh K Pai, Sanjeev Pathak, Theodore A. Petti, Rakesh Ranjan, Karl Rickels, Michael Rieser, Adelaide S. Robb, Norman E. Rosenthal, Russell Scheffer, Scott Daniel Segal, Franco Sicuro, Dwight V. Wolf, and Tony T Yang).
PII: S0890-8567(09)60109-X
doi:10.1097/CHI.0b013e3181a2b304
© 2009 American Academy of Child and Adolescent Psychiatry. Published by Elsevier Inc. All rights reserved.
Volume 48, Issue 7 , Pages 721-729, July 2009
